Hypoglycaemia and its management in primary care setting.

Area of Science:

• Endocrinology
• Metabolic Diseases
• Diabetes Management

Background:

• Hypoglycaemia is a frequent complication in type 1 and type 2 diabetes, significantly hindering glycemic control.
• It is defined as blood glucose below 70 mg/dL (3.9 mmol/L), with symptoms potentially occurring at higher levels in poorly controlled diabetes.
• Severe hypoglycaemia necessitates external assistance for recovery.

Purpose of the Study:

• To review the impact of hypoglycaemia on diabetes management.
• To discuss strategies for preventing and treating hypoglycaemic events.
• To highlight the role of newer anti-diabetic agents and technologies in mitigating hypoglycaemia risk.

Main Methods:

• Review of clinical trial data on glucose-lowering agents.
• Analysis of risk factors and vulnerable patient populations.
• Discussion of therapeutic recommendations and management protocols.

Main Results:

• Newer anti-diabetic drugs show a low risk of hypoglycaemic events compared to insulin and sulfonylureas.
• Continuous glucose monitoring (CGM) is recommended for high-risk individuals.
• Tailored treatment approaches, including GLP-1 receptor agonists and SGLT2 inhibitors, benefit frail patients with type 2 diabetes.

Conclusions:

• Individualized glycaemic goals and tailored therapies are crucial for improving patients' quality of life.
• Proactive management, including patient education and technology adoption (e.g., CGM), can significantly reduce hypoglycaemia.
• Healthcare professionals play a key role in educating patients and alleviating fear associated with hypoglycaemia.